Danfei Liu

Hubei Key Laboratory Of Hepato Pancreato Biliary Diseases
Wuhan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression.

E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression.

Journal: Gut
Published: September 23, 2024

Transcription factor ELF4 in physiology and diseases: Molecular roles and clinical implications.

Transcription factor ELF4 in physiology and diseases: Molecular roles and clinical implications.

Journal: Genes & diseases
Published: February 13, 2024

SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T-Cells Infiltration and Immunosuppression.

SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T-Cells Infiltration and Immunosuppression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 29, 2023

SRSF10 facilitates HCC growth and metastasis by suppressing CD8+T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy.

SRSF10 facilitates HCC growth and metastasis by suppressing CD8+T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy.

Journal: International immunopharmacology
Published: September 13, 2023

Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.

Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.

Journal: Frontiers in immunology
Published: July 20, 2022

FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2.

FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2.

Journal: Journal of hepatology
Published: June 06, 2022

HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET.

HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET.

Journal: Journal of experimental & clinical cancer research : CR
Published: April 15, 2022

HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing HIF1A expression.

HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing HIF1A expression.

Journal: Cancer science
Published: March 08, 2022

Correction to: ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY.

Correction to: ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY.

Journal: Cell death & disease
Published: December 24, 2021

T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.

T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.

Journal: Oncogene
Published: September 28, 2021

ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY.

ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY.

Journal: Cell death & disease
Published: August 06, 2021

Correction: SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7.

Correction: SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7.

Journal: Oncogene
Published: May 22, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026